Eblasakimab Antibody

SKU: orb1944148

Description

Eblasakimab (ASLAN004) is a humanized monoclonal antibody designed to inhibit the IL-13 receptor alpha subunit, thereby blocking signaling of IL-4 and IL-13 through the type 2 receptor. This mechanism makes it a relevant tool for investigating the pathophysiology and potential therapeutic strategies for atopic dermatitis in both in vitro and in vivo research models.

Research Area

Immunology & Inflammation

Images & Validation

−

Key Properties

−

CAS Number	2445460-16-0
MW	143.86 kDa
Purity	98.18% (SEC-HPLC)
Target	Interleukin

Bioactivity

−

In Vitro	Eblasakimab is an interleukin (IL) -13 receptor alpha1 antagonist that blocks IL-4 and IL-13 signaling through type 2 receptors.

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

CSL334, CSL-334, ASLA N004, ASLAN004

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Quick Database Links

Gene Symbol

Interleukin

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols